Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Roman F. Stemberger"'
Autor:
Raphael Rossmanith, Kai Sauerwein, Christoph B. Geier, Alexander Leiss-Piller, Roman F. Stemberger, Svetlana Sharapova, Robert W. Gruber, Helmut Bergler, James W. Verbsky, Krisztian Csomos, Jolan E. Walter, Hermann M. Wolf
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundTrichothiodystrophy-1 (TTD1) is an autosomal-recessive disease and caused by mutations in ERCC2, a gene coding for a subunit of the TFIIH transcription and nucleotide-excision repair (NER) factor. In almost half of these patients infectious
Externí odkaz:
https://doaj.org/article/1b5d1168f41441349e90021ee7aec36e
Autor:
Kai M. T. Sauerwein, Christoph B. Geier, Roman F. Stemberger, Hüseyin Akyaman, Peter Illes, Michael B. Fischer, Martha M. Eibl, Jolan E. Walter, Hermann M. Wolf
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Previous studies on immune responses following COVID-19 vaccination in patients with common variable immunodeficiency (CVID) were inconclusive with respect to the ability of the patients to produce vaccine-specific IgG antibodies, while patients with
Externí odkaz:
https://doaj.org/article/3308e5a39f834013a21b489f74acbbd1
Autor:
Kai M.T. Sauerwein, Christoph B. Geier, Roman F. Stemberger, Raphael Rossmanith, Hüseyin Akyaman, Peter Illes, Michael B. Fischer, Martha M. Eibl, Jolan E. Walter, Hermann M. Wolf
Publikováno v:
The Journal of allergy and clinical immunology.
Although previous studies described the production of IgG antibodies in a subgroup of patients with common variable immunodeficiency (CVID) following messenger RNA vaccinations with BNT162b2 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2
Autor:
Kai M T, Sauerwein, Christoph B, Geier, Roman F, Stemberger, Hüseyin, Akyaman, Peter, Illes, Michael B, Fischer, Martha M, Eibl, Jolan E, Walter, Hermann M, Wolf
Publikováno v:
Frontiers in immunology. 13
Previous studies on immune responses following COVID-19 vaccination in patients with common variable immunodeficiency (CVID) were inconclusive with respect to the ability of the patients to produce vaccine-specific IgG antibodies, while patients with